Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - Zealand Pharma to participate in the Jefferies Global Healthcare Conference
Zealand Pharma to participate in the Jefferies Global Healthcare Conference
GlobeNewswire

Press release – No. 11 / 2026 Zealand Pharma to participate in the Jefferies Global Healthcare Conference Copenhagen, Denmark, May 27, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the…

globenewswire.com - Zealand Pharma - Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions
Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions
GlobeNewswire

Press release – No. 10 / 2026 Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions Late-breaking Phase 2 ZUPREME-1 data on petrelintide to be featured as ePoster Theater presentation and poster…

fool.com - Sara Appino - PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem
PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem
The Motley Fool

The VanEck Pharmaceutical ETF (PPH 0.83%) provides targeted exposure to drug manufacturers, while the iShares Global Healthcare ETF (IXJ 0.86%) offers a broader reach across the international medical industry including biotechnology and equipment.

republicworld.com - Initiative Desk - Bollywood Actor Salim Diwan Takes Over Krux Pharma Pvt. Ltd. in 50 Million USD Deal for Strategic Global Business Expansion
Bollywood Actor Salim Diwan Takes Over Krux Pharma Pvt. Ltd. in 50 Million USD Deal for Strategic Global Business Expansion
Republic World

Bollywood actor and entrepreneur Salim Diwan has once again made headlines—this time not for a film, but for a significant business milestone. Diwan has acquired pharmaceutical company Krux Pharma Pvt. Ltd. in a deal valued at 50 million…

fool.com - Prosper Junior Bakiny - President Trump's Drug Pricing Policies Could Hurt Drugmakers' Profits. Time to Sell Pharma Stocks?
President Trump's Drug Pricing Policies Could Hurt Drugmakers' Profits. Time to Sell Pharma Stocks?
The Motley Fool

President Trump has made it a priority to address the U.S.'s high drug prices. His administration's Most-Favored-Nation (MFN) policy, centered on the idea that Americans shouldn't have to pay more for medicines than other developed nations, seeks…

marketbeat.com - HighTower Advisors LLC Lowers Holdings in BridgeBio Pharma, Inc. $BBIO
HighTower Advisors LLC Lowers Holdings in BridgeBio Pharma, Inc. $BBIO
MarketBeat

HighTower Advisors LLC cut its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 60.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor…

psychologytoday.com - David M. Carreon,  MD - Have Hope: Psychiatry Officially Embraces the Future
Have Hope: Psychiatry Officially Embraces the Future
Psychology Today

In a hallowed tradition, psychiatrists from across the country gathered together to meet and discuss our field as we have done most years since 1844. What was different this year at the American Psychiatric Association meeting was that the…

businessinsider.com - Lara O'Reilly - How to fix AI's branding problem, according to top marketers
How to fix AI's branding problem, according to top marketers
Business Insider

How do you solve a branding problem like AI? Marketers have some ideas, like borrowing from P&G's marketing playbook or creating a think tank. It's no secret that AI is getting a bad rap. Boos at college graduation speeches. AI-related layoffs.

forbes.com - Mayank Kejriwal - The Next AI Opportunity Is The Research Office
The Next AI Opportunity Is The Research Office
Forbes

Mayank Kejriwal - CEO and Co-Founder of GRAIL. ​When business leaders talk about AI, the conversation usually starts with customer service, software development or marketing. I believe one of the biggest overlooked opportunities is the…

scmp.com - Julie Zhang - China's biotech boom drives surge in home-grown innovative drug approvals
China's biotech boom drives surge in home-grown innovative drug approvals
South China Morning Post

Home-grown innovative drugs make up most of the medicines China's drug regulator has approved for sale so far this year, underscoring the country's biotech boom. Of the 19 innovative drugs cleared by the National Medical Products Administration…

seekingalpha.com - Dulan Lokuwithana - BridgeBio gains FDA review for muscle disorder drug (BBIO)
BridgeBio gains FDA review for muscle disorder drug (BBIO)
Seeking Alpha

Shares of BridgeBio Pharma () traded higher on Wednesday after the FDA granted priority review for its marketing application for BBP-418, an oral therapy targeting a rare muscle disorder called limb-girdle muscular dystrophy. The regulator has…

forbes.com - Brett Owens - This Boring Income Portfolio Strategy Could Unlock 300%+ Upside
This Boring Income Portfolio Strategy Could Unlock 300%+ Upside
Forbes

Growth business bar graph on analyzed data. Most people think you can't time the market. That's nonsense. Not only is it possible, it's easy. Today I'm going to show you how to do it with far less risk than the average investor would face. The best…

seekingalpha.com - Albert Anthony - Natera: A Growing Biotech, After Recent FDA Approval And Q1 Revenue Results (NASDAQ:NTRA)
Natera: A Growing Biotech, After Recent FDA Approval And Q1 Revenue Results (NASDAQ:NTRA)
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

thehindubusinessline.com - India on track to become stock-pickers' market in June, brokerages say
India on track to become stock-pickers' market in June, brokerages say
BusinessLine

India is likely to become a stock-pickers market in June ​as local money moves selectively into certain sectors ‌while bearish bets by overseas investors limit broader ​gains, two brokerages said. The benchmark ⁠Nifty 50…

news-medical.net - Tecan establishes direct sales and specialist lab automation service operations in India
Tecan establishes direct sales and specialist lab automation service operations in India
News-Medical

Tecan, a global provider of laboratory automation and solutions, today announced the launch of direct operations in India, including a dedicated local sales and service team based in Gurugram, near New Delhi. The launch, marked with a…

Receive a Daily briefing on Pharma Industry News

Get Started